SCHEMBL24314083

SCHEMBL24314083

CC1(F)c2ccccc2-c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 11/20 0.46
THRB P10828 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
S100A4 P26447 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
OPRK1 P41145 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MLNR O43193 1/20 0.37
NR1I2 O75469 1/20 0.37
CHRM2 P08172 1/20 0.37
ADRB1 P08588 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
CHRM1 P11229 1/20 0.37
DRD2 P14416 1/20 0.37
ADRA2B P18089 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22655432 0.77 PDK2 (0.41) PDK2THRBTDP1S100A4KDM4E
SCHEMBL29363404 0.77 HTR2A (0.48) PDK2THRBTDP1S100A4KDM4E
SCHEMBL29386757 0.77 PDK2 (0.44) PDK2THRBTDP1S100A4KDM4E
SCHEMBL29608923 0.77 PDK2 (0.50) PDK2THRBTDP1S100A4KDM4E
SCHEMBL18383337 0.77 PDK2 (0.44) PDK2THRBTDP1S100A4KDM4E
SCHEMBL2320531 0.77 PDK2 (0.50) PDK2THRBTDP1S100A4KDM4E
SCHEMBL6316881 0.77 PDK2 (0.50) PDK2THRBTDP1S100A4KDM4E
SCHEMBL283246 0.77 HTR2A (0.48) PDK2THRBTDP1S100A4KDM4E
SCHEMBL29518493 0.77 PDK2 (0.50) PDK2THRBTDP1S100A4KDM4E
SCHEMBL5887914 0.74 PDK2 (0.42) PDK2THRBTDP1S100A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023055702-A1 MAIN PROTEASE (M PRO) INHIBITORS AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2023-04-06 WO disclosed
WO-2022076820-A1 TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-04-14 WO disclosed